What is Hubei Biocause Pharmaceutical Co Price-to-Operating-Cash-Flow?
As of today (2024-05-09), Hubei Biocause Pharmaceutical Co's share price is ¥2.30.
Hubei Biocause Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-3.98. Hence, Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, Hubei Biocause Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 10100.00. The lowest was 0.47. And the median was 2.24.
Hubei Biocause Pharmaceutical Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥-4.06.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-3.98.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hubei Biocause Pharmaceutical Co was -178.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -24.60% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -19.90% per year.
During the past 13 years, Hubei Biocause Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 256.20% per year. The lowest was -81.70% per year. And the median was -16.60% per year.
Hubei Biocause Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Biocause Pharmaceutical Co Price-to-Operating-Cash-Flow Chart
|
Hubei Biocause Pharmaceutical Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
1.21 |
1.10 |
3.74 |
1.92 |
1.49 |
|
Hubei Biocause Pharmaceutical Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
0.66 |
0.47 |
0.56 |
1.49 |
- |
Competitive Comparison of Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow
For the Insurance - Life subindustry, Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Insurance Industry
For the Insurance industry and Financial Services sector, Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Hubei Biocause Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation
Hubei Biocause Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 2.30 | / | -3.978 |
| = | |
Hubei Biocause Pharmaceutical Co's Share Price of today is ¥2.30.
Hubei Biocause Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-3.98.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Hubei Biocause Pharmaceutical Co (SZSE:000627) Business Description
Traded in Other Exchanges
N/A
Address
2nd Floor, Building 1, No. 1 Tianshan Road, Guohua Huijin Center, Zhanghe New District, Hubei Province, Jingmen, CHN, 448000
Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.
Hubei Biocause Pharmaceutical Co (SZSE:000627) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:000627 has been successfully added to your